XLO Latest Press Releases

-- November 3, 2026 --

Xilio Therapeutics to Present at the Stifel 2026 Healthcare Conference Globe Newswire 4:30 PM

-- October 26, 2026 --

Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC Globe Newswire 7:30 AM

-- October 2, 2026 --

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- September 28, 2026 --

Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer Globe Newswire 7:30 AM

-- September 2, 2026 --

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- August 12, 2026 --

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates Globe Newswire 7:30 AM

-- July 6, 2026 --

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- June 29, 2026 --

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes